Compare and contrast Disseminated Intravascular Coagulation, Sepsis‑Induced Coagulopathy, and Trauma‑Induced Coagulopathy, describing each condition’s pathophysiological drivers, the recommended diagnostic scoring systems (e.g., International Society on Thrombosis and Haemostasis criteria), and evidence‑based thresholds for anticoagulation versus blood product administration.

Comparative Analysis of DIC, SIC, and TIC

Use the Sepsis-Induced Coagulopathy (SIC) scoring system for early detection of coagulopathy in septic patients, the ISTH overt DIC criteria for decompensated coagulopathy across all etiologies, and trauma-specific modifications of the JAAM DIC score for trauma patients, recognizing that these represent distinct pathophysiological entities requiring different management approaches. 1, 2, 3

Pathophysiological Drivers

Disseminated Intravascular Coagulation (DIC)

• Represents the decompensated, overt stage of systemic coagulation activation with consumption of clotting factors and platelets 1
• Characterized by systemic coagulation activation, impaired fibrinolysis, and endothelial injury leading to both microvascular thrombosis and bleeding 4
• Can occur from multiple etiologies including sepsis, trauma, malignancy, and obstetric complications 1
• Progresses through phases: pre-DIC → early-phase (compensated) DIC → overt DIC with clinical manifestations 4

Sepsis-Induced Coagulopathy (SIC)

• Represents the early, compensated phase of sepsis-associated DIC that precedes overt DIC 1
• Driven by inflammation-mediated coagulation activation where inflammatory mediators promote endothelial injury and dysregulated coagulation 5
• Lacks an initial hemorrhagic phase, instead presenting with prothrombotic features and multiorgan dysfunction early in the disease course 5
• Approximately 60% of septic patients develop SIC, which is twice the incidence of overt DIC 1
• Almost all patients with overt DIC in sepsis were diagnosed with SIC earlier in their disease course 1

Trauma-Induced Coagulopathy (TIC)

• Presents initially with a hemorrhagic phenotype in approximately 25% of severely injured patients on hospital arrival 5
• Driven by massive blood loss, extensive tissue damage, and hyperfibrinolysis in the acute phase 5
• Progresses through distinct phases: initial impaired hemostasis with bleeding → prothrombotic phase with fibrinolytic shutdown after hemorrhage control 5
• The prothrombotic progression is promoted by inflammatory mediator release, endothelial injury, and platelet dysregulation 5
• Survivors may subsequently develop infections leading to SIC, creating overlapping pathophysiology 5

Diagnostic Scoring Systems

ISTH Overt DIC Criteria (2001, Updated 2025)

Components and Scoring: 1, 4

• Platelet count: <50 × 10⁹/L = 2 points; 50-100 × 10⁹/L = 1 point
• D-dimer (2025 update): >7× upper normal limit = 3 points; >3× upper normal limit = 2 points 4
• Prothrombin time: ≥6 seconds prolonged = 2 points; 3-6 seconds = 1 point
• Fibrinogen: <100 mg/dL = 1 point
• Diagnosis threshold: ≥5 points indicates overt DIC 1
• Performance: Represents the gold standard for decompensated DIC but has lower sensitivity for early detection 1

SIC Scoring System (2019)

Components and Scoring: 1

• Platelet count: <100 × 10⁹/L = 2 points; 100-150 × 10⁹/L = 1 point
• PT ratio: >1.4 = 2 points; 1.2-1.4 = 1 point
• SOFA score: ≥2 = 2 points; 1 = 1 point
• Diagnosis threshold: ≥4 points indicates SIC 1
• Performance: Sensitivity of 86.8% for predicting 28-day mortality, significantly higher than overt DIC (64.5%) 6
• Temporal relationship: 98.7% of patients with overt DIC had prior SIC diagnosis; 93.9% who developed overt DIC between days 2-4 had baseline SIC 6
• Prognostic accuracy: Demonstrated superior calibration and discrimination (AUROC 0.779) for 28-day mortality compared to other scoring systems 7

JAAM DIC Criteria (Modified for Trauma)

Standard JAAM Components: 1

• Platelet count: <80 × 10⁹/L = 3 points; 80-120 × 10⁹/L = 1 point
• FDP: ≥25 μg/mL = 3 points; 10-25 μg/mL = 1 point
• PT ratio: ≥1.2 = 1 point
• SIRS score: >3 = 1 point
• Diagnosis threshold: ≥4 points

Trauma-Specific Modifications (2026): 3

• Optimal cutoff values for trauma: PT-INR 1.080, FDP 116.0 μg/mL, platelet count 17.0 × 10⁴/μL
• Performance: The trauma-specific DIC score outperformed conventional JAAM DIC for predicting all-cause mortality, 24-hour mortality, TBI-induced death, and massive transfusion requirements 3
• Caveat: Standard JAAM DIC was not independently associated with 28-day mortality in sepsis patients (RR 1.115,95% CI 0.660-1.182) 7

European Trauma Guidelines Approach

• PTr thresholds: PTr >1.2 defines traumatic coagulopathy; PTr >1.5 indicates severe coagulopathy 2
• Fibrinogen threshold: Clauss fibrinogen <1.3 g/L associated with increased mortality 2
• POC-PTr reliability: Good accuracy when values <2.0, with thresholds of 1.2 and 1.4 detecting moderate and severe coagulopathy respectively 2

Evidence-Based Thresholds for Anticoagulation vs Blood Products

Anticoagulation Thresholds

For SIC/Sepsis-Associated DIC:

• Initiation threshold: SIC score ≥4 can be used for patient selection for anticoagulant therapy, given mortality ≥30% 1
• Alternative approach: SIC score >3 on day 1 showed 72% sensitivity for identifying pre-DIC, supporting earlier intervention 8
• Cumulative scoring: Sum of SIC scores on days 1 and 3 (AUC 0.79) provides better pre-DIC identification than single timepoint 8
• Favorable outcomes: Anticoagulant therapy showed benefit in SIC-positive patients (adjusted HR 0.216,95% CI 0.060-0.783) 8

Anticoagulant Options (No Robust Evidence): 1, 9

• Heparin, antithrombin, and recombinant thrombomodulin are candidates
• Japanese guidelines recommend antithrombin and recombinant thrombomodulin for sepsis-associated DIC 9
• Critical limitation: No anticoagulant has proven effective with robust evidence; future trials are warranted 1

For Trauma:

• Tranexamic acid: Recommended within limited timing window of initial traumatic injury 5
• Anticoagulation generally contraindicated in acute hemorrhagic phase of TIC 5
• Consider anticoagulation only after transition to prothrombotic/fibrinolytic shutdown phase 5

Blood Product Thresholds

Trauma-Specific Thresholds: 2

• PTr >1.2: Initiate hemostatic resuscitation protocols
• PTr >1.5: Indicates severe coagulopathy requiring aggressive transfusion
• Fibrinogen <1.3 g/L: Threshold for fibrinogen replacement (associated with mortality)
• Platelet count <100 × 10⁹/L: Consider platelet transfusion in bleeding patients
• Viscoelastic-guided approach: VEM-guided algorithms showed potential benefit in TBI subgroup (28-day mortality: VEM 44% vs CCT 74%, OR 0.28) 2

DIC/SIC Blood Product Support:

• Blood product administration primarily supportive, guided by clinical bleeding and laboratory parameters 1
• No specific transfusion thresholds established in guidelines for SIC/DIC 1
• Focus on treating underlying cause (infection vs tissue injury) is critical 5

Algorithmic Approach to Diagnosis and Management

Step 1: Identify Clinical Context

• Sepsis: Use SIC scoring system for early detection 1
• Trauma: Use trauma-specific DIC modifications or PTr-based approach 2, 3
• Other etiologies: Use ISTH overt DIC criteria 4

Step 2: Apply Appropriate Scoring System

• For sepsis: Calculate SIC score (platelet, PT ratio, SOFA); ≥4 indicates SIC 1
• For trauma: Calculate PTr; >1.2 indicates coagulopathy, >1.5 severe 2
• For overt DIC: Calculate ISTH score; ≥5 indicates overt DIC 1

Step 3: Determine Phase and Phenotype

• SIC (score ≥4): Early compensated phase, high risk for progression to overt DIC 1
• Overt DIC (score ≥5): Decompensated phase with consumption 4
• TIC: Assess for hemorrhagic vs prothrombotic phase based on timing and clinical presentation 5

Step 4: Treatment Decision

• SIC with score ≥4: Consider anticoagulation (mortality ≥30%), though evidence remains limited 1, 8
• Trauma with PTr >1.2: Initiate hemostatic resuscitation; consider tranexamic acid if within appropriate time window 2, 5
• Overt DIC: Treat underlying cause; supportive blood product therapy as needed 1

Critical Pitfalls and Caveats

Diagnostic Pitfalls

• Fibrinogen levels often do not decrease in sepsis, making it less useful for SIC diagnosis 1
• D-dimer cutoff values not unified between measurement assays, limiting standardization 1
• Platelet counts fall late in trauma hemorrhage and poorly reflect platelet dysfunction 2
• POC-PTr precision decreases as PTr rises above 2.0 2

Management Pitfalls

• No anticoagulant has robust evidence for efficacy in sepsis-associated DIC; clinical trials have included patients without coagulopathy 1
• Anticoagulation in acute hemorrhagic TIC is contraindicated; timing is critical 5
• VEM-guided transfusion showed benefit primarily in TBI subgroup, not broadly applicable 2
• Two-step approach using SIC followed by overt DIC criteria represents novel strategy for severity assessment 9

Temporal Considerations

• Serial measurements critical: SIC on days 2,4, and 7 maintained significantly higher sensitivity (96.1%, 92.3%, 84.4%) than overt DIC for mortality prediction 6
• Sum of SIC scores on days 1 and 3 provides superior pre-DIC identification (AUC 0.79) compared to single timepoint 8
• TIC evolves from hemorrhagic to prothrombotic phase; management must adapt accordingly 5